僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Enlimomab （BI-RR 0001）, a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research